Follow-up for certain early esophageal cancer found by endoscopy
Part of Cancer, Digestive system clinical trials.
This study follows people whose early esophageal adenocarcinoma was found during an endoscopy (ER) sample. The goal is to better understand what follow-up tests are needed based on higher-risk features and to watch for spread or incomplete removal.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your esophageal cancer diagnosis came from an endoscopy sample (ER) and was labeled as submucosal or high-risk mucosal adenocarcinoma by GI pathology experts
- You have signed the study consent form
- Your prior history does not include high-risk mucosal cancer or cancer that had reached at least the submucosal layer (≥T1sm)
- No signs are found that the cancer has spread (no lymph node or distant metastasis) on EUS, neck ultrasound, and CT scans done about 6 weeks after the endoscopy
- The cancer was completely removed at the time of endoscopy (no positive deep margin, called R1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests less invasive ways to detect high-grade dysplasia (very abnormal cells) and esophageal cancer in people with Barrett's esophagus, a condition that can increase cancer risk. It looks for these changes using cell samples taken during a routine endoscopy, which may be quicker and more comfortable than standard biopsies.
This trial is checking outcomes for adults who are scheduled to have a procedure called endoscopic submucosal dissection (ESD), done through an endoscope. If you’re already planned for ESD and have no reasons you can’t have endoscopy, you may be able to join.
This study looks at people with Barrett's esophagus who are about to have a procedure to remove a suspicious spot. It tests a new way to predict if cancer might come back, and it checks how learning your risk affects your worry and quality of life.
This study compares two approaches for people with Barrett's esophagus and low-grade dysplasia: regular surveillance (monitoring with endoscopies) versus endoscopic treatment to remove the abnormal cells. It aims to see which approach is better at preventing progression to more serious conditions.
This study tests a less invasive way to check for Barrett's esophagus and esophageal cancer. Instead of a standard endoscopy, they may use a sponge-on-a-string or other simpler methods, which could be more comfortable and easier for patients.
This study collects information from people who are already being screened for Barrett's esophagus or esophageal cancer using the EsoCheck and EsoGuard tests. It helps doctors learn more about how well these tests work in real life.
Hear when a new Barrett Esophagus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.